Continue Reading →
The company’s revolutionary treatment and recovery program, using the product Ibogaine, will initially focus on the opioid epidemic in British Columbia followed by North America.
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/ypBoaytF37qb/info/
Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico
Thomas Kingsley Brown, PhD
This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at ...Continue Reading →
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/w5HzSJBjBSdf/info/
Notes on Progress in the New Zealand Ibogaine Study
Geoff Noller, PhD
This presentation reports on the first year of progress in the New Zealand observational study of ibogaine treatment outcomes for opioid-dependent persons. Current participants’ data are reviewed and the implications of New Zealand’s ibogaine legislation for research and treatment are discussed.
Dr. Geoff Noller has a background in ...Continue Reading →